Clinical trial
Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile
NCT01320397 is registered in ClinicalTrials.gov with RostaQuo S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile
- Lead sponsor
- RostaQuo S.p.A.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 31, 2011
- Completion date
- December 31, 2012
- Enrollment
- 240 (estimated)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.